HIV/AIDS Therapy
New HIV/AIDS therapy study findings recently were reported by U.S. Kristoffersen and co-researchers
Published in AIDS Weekly, February 23rd, 2009
Researchers detail in 'Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy,' new data in HIV/AIDS. According to recent research from Copenhagen, Denmark, "Antiretroviral therapy (ART) in HIV-infected patients is associated with increased cardiovascular risk. Circulating markers of endothelial dysfunction may be used to study early atherogenesis."
"The aim of our study was to investigate changes in such markers during initiation of ART. In 115 HIV-positive treatment-naïve patients, plasma lipids, E-selectin, soluble intercellular adhesion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-02-23)
More Articles from AIDS Weekly
- Aethlon Medical, Inc.
Aethlon Medical Announces Expansion Into the Infectious Disease Diagnostic Market - HIV/AIDS
New HIV/AIDS study findings have been published by scientists at University of California - HIV/AIDS
New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide - HIV/AIDS
Research from New York Blood Center reveals new findings on HIV/AIDS - HIV/AIDS
Scientists at Johns Hopkins University, Medical Department publish new data on HIV/AIDS - HIV/AIDS
University of Ottawa publishes research in HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
